KDM2B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.377400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.338000E-01
Normal-vs-Stage2
2.431200E-01
Normal-vs-Stage3
1.745590E-01
Normal-vs-Stage4
2.177200E-01
Stage1-vs-Stage2
8.016000E-01
Stage1-vs-Stage3
1.058220E-01
Stage1-vs-Stage4
6.741600E-01
Stage2-vs-Stage3
1.473250E-01
Stage2-vs-Stage4
6.035800E-01
Stage3-vs-Stage4
2.358400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.426800E-01
Normal-vs-AfricanAmerican
2.413200E-01
Normal-vs-Asian
1.910770E-01
Caucasian-vs-AfricanAmerican
8.625200E-01
Caucasian-vs-Asian
8.400000E-02
AfricanAmerican-vs-Asian
2.774600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.329200E-01
Normal-vs-Female
2.453200E-01
Male-vs-Female
4.744800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.198800E-01
Normal-vs-Age(41-60Yrs)
2.683800E-01
Normal-vs-Age(61-80Yrs)
2.241600E-01
Normal-vs-Age(81-100Yrs)
2.344600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.830000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.818800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.109400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.513560E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.517800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.392200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.387800E-01
Normal-vs-Daily Drinker
2.377200E-01
Normal-vs-Weekly Drinker
2.223200E-01
Normal-vs-Occasional Drinker
2.204800E-01
Normal-vs-Social Drinker
2.507400E-01
Non Drinker-vs-Daily Drinker
9.994200E-01
Non Drinker-vs-Weekly Drinker
6.779200E-01
Non Drinker-vs-Occasional Drinker
5.740200E-01
Non Drinker-vs-Social Drinker
7.569400E-01
Daily Drinker-vs-Weekly Drinker
6.127400E-01
Daily Drinker-vs-Occasional Drinker
5.307800E-01
Daily Drinker-vs-Social Drinker
6.942800E-01
Weekly Drinker-vs-Occasional Drinker
9.835200E-01
Weekly Drinker-vs-Social Drinker
4.066000E-01
Occasional Drinker-vs-Social Drinker
2.685800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.627800E-01
Normal-vs-Grade 2
8.162800E-01
Normal-vs-Grade 3
7.967800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.689400E-01
Grade 1-vs-Grade 3
6.111600E-01
Grade 1-vs-Grade 4
6.627800E-01
Grade 2-vs-Grade 3
6.645000E-01
Grade 2-vs-Grade 4
8.162800E-01
Grade 3-vs-Grade 4
7.967800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.450600E-01
Normal-vs-NonDiabetic
2.273800E-01
Diabetic-vs-NonDiabetic
5.197400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.185800E-01
Normal-vs-NoPancreatitis
2.337400E-01
Pancreatitis-vs-NoPancreatitis
4.245600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.247200E-01
Normal-vs-N1
2.454800E-01
N0-vs-N1
2.557200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.981820E-01
Normal-vs-TP53-NonMutant
2.427400E-01
TP53-Mutant-vs-TP53-NonMutant
6.871700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
